What are the risks of poor blood sugar control shown by high HbA1c?

High HbA1c levels indicate poor blood sugar control over 2-3 months, increasing risks of heart disease, nerve damage, kidney disease, vision loss, and cognitive decline. Even slightly elevated levels can damage blood vessels and organs, making regular monitoring and early intervention crucial for preventing complications.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding HbA1c and Its Role in Blood Sugar Control

HbA1c, or hemoglobin A1c, is a blood test that provides a snapshot of your average blood sugar levels over the past 2-3 months. Unlike a single glucose reading that captures a moment in time, HbA1c reveals the bigger picture of how well your body has been managing blood sugar. This test measures the percentage of hemoglobin proteins in your red blood cells that have glucose attached to them—a process called glycation.

When blood sugar levels remain elevated, more glucose binds to hemoglobin, resulting in a higher HbA1c percentage. For people without diabetes, normal HbA1c levels typically range from 4% to 5.6%. Levels between 5.7% and 6.4% indicate prediabetes, while 6.5% or higher suggests diabetes. However, even levels at the higher end of 'normal' can signal metabolic dysfunction and increased health risks.

The beauty of HbA1c testing lies in its ability to reveal patterns that daily glucose checks might miss. Since red blood cells live for about 120 days, the test effectively shows your blood sugar control over this entire period, making it invaluable for detecting chronic elevation that can silently damage your body. Regular HbA1c monitoring helps identify problems early, when lifestyle changes can make the biggest difference.

HbA1c Levels and Cardiovascular Risk

HbA1c LevelCategoryCVD Risk IncreaseClinical Implications
Below 5.5%<5.5%OptimalBaselineLowest risk, ideal target
5.5-5.9%5.5-5.9%Normal-High10-15%Monitor annually, lifestyle focus
6.0-6.4%6.0-6.4%Prediabetes20-30%Aggressive lifestyle intervention
6.5-7.0%6.5-7.0%Diabetes40-60%Consider medication, intensive management
Above 7.0%>7.0%Uncontrolled2-4x higherImmediate intervention required

Risk percentages are relative to optimal HbA1c levels below 5.5%

Cardiovascular Complications from Elevated HbA1c

How High Blood Sugar Damages Blood Vessels

Chronically elevated blood sugar acts like sandpaper on your blood vessels, causing inflammation and damage to the delicate endothelial lining. This process, called endothelial dysfunction, is the first step in atherosclerosis—the buildup of plaque in arteries. High glucose levels also increase the production of advanced glycation end products (AGEs), which make blood vessels stiff and less responsive to the body's needs.

Research shows that for every 1% increase in HbA1c above normal, the risk of cardiovascular disease rises by approximately 18%. This relationship exists even in people without diagnosed diabetes. The damage occurs through multiple mechanisms: high blood sugar promotes inflammation, increases oxidative stress, and alters lipid metabolism, creating a perfect storm for heart disease.

Increased Risk of Heart Attack and Stroke

People with HbA1c levels above 7% face a two to four times higher risk of heart attack compared to those with optimal levels. The risk isn't limited to those with diabetes—even prediabetic HbA1c levels (5.7-6.4%) increase cardiovascular event risk by 20-30%. High blood sugar accelerates the formation of blood clots, damages the heart muscle directly, and can lead to irregular heart rhythms.

Stroke risk follows a similar pattern. Elevated HbA1c levels increase the likelihood of both ischemic strokes (caused by blood clots) and hemorrhagic strokes (caused by bleeding). The small blood vessels in the brain are particularly vulnerable to glucose-related damage, and chronic elevation can lead to silent mini-strokes that accumulate over time, contributing to vascular dementia.

Nerve Damage and Neuropathy

Peripheral Neuropathy Development

Diabetic neuropathy affects up to 50% of people with chronically elevated HbA1c levels. High blood sugar damages the small blood vessels that supply nerves, particularly in the feet and hands. This damage typically starts with tingling or numbness in the toes and gradually progresses upward. The condition can range from mild discomfort to severe pain that significantly impacts quality of life.

The relationship between HbA1c and neuropathy risk is dose-dependent—higher levels and longer duration of elevation increase the likelihood and severity of nerve damage. Studies show that maintaining HbA1c below 7% can reduce neuropathy risk by up to 60%. Early detection through regular foot exams and prompt blood sugar control can prevent progression and potentially reverse early nerve damage.

Autonomic Nervous System Effects

Beyond peripheral nerves, high HbA1c can damage the autonomic nervous system, which controls involuntary functions like heart rate, digestion, and blood pressure. This can lead to gastroparesis (delayed stomach emptying), erectile dysfunction, bladder problems, and dangerous drops in blood pressure when standing. These complications often develop silently and can significantly impact daily life by the time symptoms appear.

Kidney Disease and HbA1c

The kidneys filter about 180 liters of blood daily, and their delicate filtering units (nephrons) are extremely vulnerable to high blood sugar. Elevated HbA1c levels indicate chronic hyperglycemia that damages these filters, leading to diabetic nephropathy—the leading cause of kidney failure worldwide. The progression typically follows a predictable pattern: microalbuminuria (small amounts of protein in urine), followed by increasing proteinuria, declining kidney function, and eventually kidney failure.

Research demonstrates that keeping HbA1c below 7% can reduce the risk of kidney disease by 30-50%. However, even modestly elevated levels (6.0-6.5%) increase the risk of chronic kidney disease. The damage occurs through multiple pathways: direct glucose toxicity to kidney cells, increased blood pressure within the kidneys, and activation of inflammatory pathways. Regular monitoring of both HbA1c and kidney function markers like creatinine and albumin can catch problems early when intervention is most effective.

Vision Problems and Eye Complications

Diabetic Retinopathy Risk

Diabetic retinopathy remains the leading cause of blindness in working-age adults, and HbA1c levels directly correlate with risk. The tiny blood vessels in the retina are among the first to show damage from chronic hyperglycemia. Initially, these vessels may leak fluid or blood, causing blurred vision. As damage progresses, new abnormal blood vessels grow, which can bleed into the eye and cause severe vision loss or blindness.

Studies show that for every 1% reduction in HbA1c, the risk of retinopathy decreases by approximately 35%. The condition often develops without symptoms in early stages, making regular eye exams crucial for anyone with elevated HbA1c. Modern treatments can prevent vision loss if caught early, but prevention through blood sugar control remains the best strategy.

Other Eye Complications

Beyond retinopathy, high HbA1c increases the risk of cataracts by 2-5 times and doubles the risk of glaucoma. High blood sugar causes the lens of the eye to swell and become cloudy more quickly, leading to earlier cataract formation. It also affects the fluid pressure within the eye, contributing to glaucoma development. These conditions can compound each other, making comprehensive eye care essential for anyone with chronically elevated blood sugar.

Cognitive Decline and Brain Health

Emerging research reveals a strong connection between chronically elevated HbA1c and cognitive decline. High blood sugar damages brain blood vessels, reduces blood flow, and promotes the formation of amyloid plaques associated with Alzheimer's disease. People with HbA1c levels above 7% show faster rates of brain atrophy and have a 50% higher risk of developing dementia compared to those with optimal levels.

The brain consumes about 20% of the body's glucose, making it particularly sensitive to blood sugar fluctuations. Chronic hyperglycemia impairs the brain's ability to use glucose effectively, leading to energy deficits that affect memory, processing speed, and executive function. Studies show that even prediabetic HbA1c levels (5.7-6.4%) are associated with subtle cognitive changes and increased risk of mild cognitive impairment.

Immune System Dysfunction

High HbA1c levels significantly impair immune function, making the body more susceptible to infections and slower to heal. Elevated blood sugar interferes with white blood cell function, reducing their ability to find and destroy pathogens. This explains why people with poor blood sugar control experience more frequent and severe infections, from urinary tract infections to pneumonia.

The immune dysfunction extends to wound healing. High glucose levels reduce blood flow to tissues, impair collagen production, and create an environment where bacteria thrive. This combination can turn minor cuts into serious infections, particularly in the feet where circulation is already compromised. Studies show that normalizing HbA1c can restore much of the immune system's function, reducing infection risk by up to 40%.

Monitoring and Prevention Strategies

Regular HbA1c testing provides invaluable insight into your metabolic health before serious complications develop. For those with normal levels, annual testing may suffice, but anyone with prediabetes or risk factors should test every 3-6 months. This frequency allows you to track trends and adjust lifestyle interventions before damage occurs.

Prevention strategies focus on maintaining stable blood sugar through diet, exercise, stress management, and adequate sleep. A diet rich in whole foods, fiber, and healthy fats while limiting refined carbohydrates can significantly improve HbA1c levels. Regular physical activity enhances insulin sensitivity, with both aerobic exercise and strength training showing benefits. Even modest weight loss of 5-10% can dramatically improve blood sugar control.

Stress management techniques like meditation, yoga, or deep breathing exercises help regulate cortisol levels that can spike blood sugar. Prioritizing 7-9 hours of quality sleep supports healthy glucose metabolism. When lifestyle changes aren't enough, medications can help, but early intervention with lifestyle modifications often prevents the need for pharmaceutical intervention.

Taking Action for Better Blood Sugar Control

The risks associated with elevated HbA1c are serious but largely preventable. Every percentage point reduction in HbA1c translates to meaningful reductions in complication risk across all organ systems. The key is early detection and consistent management—waiting until symptoms appear often means significant damage has already occurred.

Start by knowing your numbers through regular testing and work with healthcare providers to develop a personalized plan. Small, sustainable changes in diet and lifestyle can yield significant improvements in HbA1c levels within just a few months. Remember that blood sugar control is not just about preventing diabetes—it's about optimizing your overall health, protecting your organs, and maintaining quality of life as you age. The investment you make in blood sugar control today pays dividends in healthier years ahead.

References

  1. Stratton, I. M., Adler, A. I., Neil, H. A., Matthews, D. R., Manley, S. E., Cull, C. A., ... & Holman, R. R. (2000). Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ, 321(7258), 405-412.[PubMed][DOI]
  2. Selvin, E., Steffes, M. W., Zhu, H., Matsushita, K., Wagenknecht, L., Pankow, J., ... & Brancati, F. L. (2010). Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. New England Journal of Medicine, 362(9), 800-811.[PubMed][DOI]
  3. Crane, P. K., Walker, R., Hubbard, R. A., Li, G., Nathan, D. M., Zheng, H., ... & Larson, E. B. (2013). Glucose levels and risk of dementia. New England Journal of Medicine, 369(6), 540-548.[PubMed][DOI]
  4. Nathan, D. M., Genuth, S., Lachin, J., Cleary, P., Crofford, O., Davis, M., ... & Siebert, C. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine, 329(14), 977-986.[PubMed][DOI]
  5. Khaw, K. T., Wareham, N., Bingham, S., Luben, R., Welch, A., & Day, N. (2004). Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Annals of Internal Medicine, 141(6), 413-420.[PubMed][DOI]
  6. Rawlings, A. M., Sharrett, A. R., Schneider, A. L., Coresh, J., Albert, M., Couper, D., ... & Selvin, E. (2014). Diabetes in midlife and cognitive change over 20 years: a cohort study. Annals of Internal Medicine, 161(11), 785-793.[PubMed][DOI]

Frequently Asked Questions

How can I test my HbA1c at home?

You can test your HbA1c at home with SiPhox Health's Core Health Program, which includes HbA1c testing along with other essential metabolic markers. This CLIA-certified program provides lab-quality results from the comfort of your home, with testing available monthly, quarterly, or every 6 months.

What HbA1c level should I aim for to minimize health risks?

While the standard target for people with diabetes is below 7%, optimal metabolic health suggests aiming for 5.4% or lower. Levels between 5.7-6.4% indicate prediabetes and increased risk for complications. Even within the 'normal' range, lower is generally better for long-term health outcomes.

How quickly can HbA1c levels improve with lifestyle changes?

Since HbA1c reflects average blood sugar over 2-3 months, you'll typically see meaningful changes within 3 months of implementing lifestyle modifications. Some people see improvements of 0.5-1.0% or more through diet, exercise, and weight loss alone. Consistent daily habits are key to sustained improvement.

Can high HbA1c be reversed without medication?

Yes, many people successfully lower HbA1c through lifestyle changes alone, especially when caught early. A combination of dietary modifications, regular exercise, weight loss, stress management, and improved sleep can reduce HbA1c by 1-2% or more. However, some individuals may need medication depending on their levels and underlying conditions.

What's the difference between HbA1c and regular glucose testing?

Regular glucose testing provides a snapshot of your blood sugar at a single moment, while HbA1c shows your average levels over 2-3 months. Glucose tests can fluctuate based on recent meals, stress, or activity, but HbA1c gives a more stable picture of overall blood sugar control, making it better for assessing long-term risk.

At what HbA1c level do complications typically start?

Research shows that complication risk begins to rise even at HbA1c levels above 5.5%, though the risk accelerates significantly above 6.5%. Microvascular complications like nerve and kidney damage often appear first, while cardiovascular risks increase progressively with any elevation above optimal levels.

Related Articles

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details